Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
The mechanism of apoptosis has been extensively characterized over the past decade, but little is known about alternative forms of regulated cell death. Although stimulation of the Fas/TNFR receptor family triggers a canonical 'extrinsic' apoptosis pathway, we demonstrated that in the absence of intracellular apoptotic signaling it is capable of activating a common nonapoptotic death pathway, which we term necroptosis. We showed that necroptosis is characterized by necrotic cell death morphology and activation of autophagy. We identified a specific and potent small-molecule inhibitor of necroptosis, necrostatin-1, which blocks a critical step in necroptosis. We demonstrated that necroptosis contributes to delayed mouse ischemic brain injury in vivo through a mechanism distinct from that of apoptosis and offers a new therapeutic target for stroke with an extended window for neuroprotection. Our study identifies a previously undescribed basic cell-death pathway with potentially broad relevance to human pathologies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Necroptosis is a form of RCD initiated by perturbations of the extracellular or intracellular microenvironment detected by specific death receptors, including (but not limited to) FAS and TNFR1 [423–427], or pathogen recognition receptors (PRRs), including TLR3, TLR4, and Z-DNA binding protein 1 (ZBP1; also known as DAI) [428–430].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [425]
In the citing paper
“Accordingly, chemical inhibitors of RIPK1 including necrostatin-1 (Nec-1) and derivatives (e.g., Nec-1s) robustly inhibit TNFR1-driven necroptosis, in vitro and in vivo [425, 427].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [425]
Citations
Cites
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.
Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y., & Yoshimori, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5720 · Cited by 6,605
Self-citationAutophagy as a Regulated Pathway of Cellular Degradation
Klionsky, D. J., & Emr, S. D. (2000) · Science · doi:10.1126/science.290.5497.1717 · Cited by 3,608 · cited 1×
“Activation of autophagy by necroptotic signaling Autophagy, a large-scale protein degradation and catabolic mechanis”
The role of autophagy during the early neonatal starvation period
Kuma, A., Hatano, M., Matsui, M., Yamamoto, A., Nakaya, H., Yoshimori, T., Ohsumi, Y., Tokuhisa, T., & Mizushima, N. (2004) · Nature · doi:10.1038/nature03029 · Cited by 2,865 · cited 1×
“4e and data not shown), in autophagy-deficient Atg5 −/− MEF cell”
Self-citationHoller, N., Zaru, R., Micheau, O., Thome, M., Attinger, A., Valitutti, S., Bodmer, J.-L., Schneider, P., Seed, B., & Tschopp, J. (2000) · Nature Immunology · doi:10.1038/82732 · Cited by 1,938
Mechanisms, challenges and opportunities in stroke
Lo, E. H., Dalkara, T., & Moskowitz, M. A. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1106 · Cited by 1,781
Self-citationGrowth factor regulation of autophagy and cell survival in the absence of apoptosis
Lum, J. J., Bauer, D. E., Kong, M., Harris, M. H., Li, C., Lindsten, T., & Thompson, C. B. (2005) · Cell · doi:10.1016/j.cell.2004.11.046 · Cited by 1,487
LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation
Kabeya, Y., Mizushima, N., Yamamoto, A., Oshitani-Okamoto, S., Ohsumi, Y., & Yoshimori, T. (2004) · Journal of Cell Science · doi:10.1242/jcs.01131 · Cited by 1,394
Self-citationAutophagy as a cell death and tumor suppressor mechanism
Gozuacik, D., & Kimchi, A. (2004) · Oncogene · doi:10.1038/sj.onc.1207521 · Cited by 1,384 · cited 1×
“, has been implicated in caspase-independent cell deat”
TUMOR NECROSIS FACTOR RECEPTOR AND Fas SIGNALING MECHANISMS
Wallach, D., Varfolomeev, E. E., Malinin, N. L., Goltsev, Y. V., Kovalenko, A. V., & Boldin, M. P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.331 · Cited by 1,312 · cited 10×
“2f), whereas it completely inhibited the appearance of necrotic morphology (nuclear condensation, organelle swelling, early loss of plasma membrane integrity and Nec-1 0 20 40 60 80 100 V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% )…”
InfluentialIntracellular ATP levels determine cell death fate by apoptosis or necrosis.
Eguchi, Y., Shimizu, S., & Tsujimoto, Y. (1997) · PubMed · Cited by 1,243
Cited by
Items 401–500 of 1,015
Zhong, T., Zhang, W., Guo, H., Pan, X., Chen, X., He, Q., Yang, B., & Ding, L. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.11.001 · Cited by 145
RIPK1- and RIPK3-induced cell death mode is determined by target availability
Cook, W. D., Moujalled, D. M., Ralph, T. J., Lock, P., Young, S. N., Murphy, J. M., & Vaux, D. L. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.70 · Cited by 153
“This form of cell death, termed ‘necroptosis’, can often be blocked by necrostatin-1 (nec-1), an inhibitor of the kinase activity of receptor-interacting protein kinase 1 (RIPK1).(3,4)”
BackgroundThe walking dead: macrophage inflammation and death in atherosclerosis
Kavurma, M. M., Rayner, K. J., & Karunakaran, D. (2017) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000394 · Cited by 156
Harnessing TRAIL-induced cell death for cancer therapy: a long walk with thrilling discoveries
Montinaro, A., & Walczak, H. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-01059-z · Cited by 171
“It was further shown that mainly the kinase activity of RIPK1 was required for mediating necroptosis via identification of the specific RIPK1 inhibitor necrostatin, capable of blocking this kind of cell death [77].”
BackgroundInsights on the crosstalk among different cell death mechanisms
Eskander, G., AbdelHamid, S. G., Wahdan, S. A., & Radwan, S. M. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02328-9 · Cited by 169
“This was con fi rmed, upon using necrostatin-1, a necroptosis inhibitor, the expression of LC3-II decreased, thus blocking autophagy [145].”
Chou, T., Li, K., Frankowski, K. J., Schoenen, F. J., & Deshaies, R. J. (2013) · ChemMedChem · doi:10.1002/cmdc.201200520 · Cited by 140
Harris, P. A., Bandyopadhyay, D., Berger, S. B., Campobasso, N., Capriotti, C. A., Cox, J. A., Dare, L., Finger, J. N., Hoffman, S. J., Kahler, K. M., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400382p · Cited by 137
Role of necroptosis in the pathogenesis of solid organ injury
Zhao, H., Jaffer, T., Eguchi, S., Wang, Z., Linkermann, A., & Ma, D. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.316 · Cited by 160
“Ischemic stroke: The pathological relevance of necroptosis in an ischemic stroke setting was established in a study by Degterev et al.(38) In a mouse model of transient focal cerebral”
BackgroundAntigen-mediated T cell expansion regulated by parallel pathways of death
Ch'en, I. L., Beisner, D. R., Degterev, A., Lynch, C., Yuan, J., Hoffmann, A., & Hedrick, S. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808043105 · Cited by 141
“Recently, TNF-induced necrosis was examined by screening for small molecule inhibitors (30).”
BackgroundSelf-citationYelamanchili, S. V., Lamberty, B. G., Rennard, D. A., Morsey, B. M., Hochfelder, C. G., Meays, B. M., Levy, E., & Fox, H. S. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1005032 · Cited by 139
“The development of the RIPK1 inhibitor Nec-1 has been a major breakthrough in research on necroptosis, and the first disease model in which the role of necroptosis was investigated was ischemic brain injury [50].”
Guadagno, J., Xu, X., Karajgikar, M., Brown, A., & Cregan, S. P. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.59 · Cited by 141
“Moreover, depending on the cellular context, TNFa can induce cell death via caspase-8-mediated apoptosis or RIPK1-mediated necroptosis.(16,17) However, the mechanism by which TNFa signaling affects NPC survival has not been defined.”
BackgroundShikonin Kills Glioma Cells through Necroptosis Mediated by RIP-1
Huang, C., Luo, Y., Zhao, J., Yang, F., Zhao, H., Fan, W., & Ge, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066326 · Cited by 141
“As a potent necroptosis inhibitor, Nec-1 was previously thought not to inhibit apoptosis and could be used to differentiate necroptosis from apoptosis [8], despite that Wang YQ et al found that Nec-1 suppressed apoptosis in mice traumatic brain injury model [29].”
BackgroundSuppression of RIP3-dependent Necroptosis by Human Cytomegalovirus
Omoto, S., Guo, H., Talekar, G. R., Roback, L., Kaiser, W. J., & Mocarski, E. S. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.646042 · Cited by 141
“Furthermore, treatment with RIP3 inhibitor GSK 840 (3 M) (30) or RIP1 kinase inhibitor necrostatin-1 (30 M) (21) reversed the pattern of death (Fig.”
BackgroundSun, W. C., Wu, X., Gao, H., Yu, J. Z., Zhao, W., Lu, J., Wang, J., Du, G., & Chen, X. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.04.010 · Cited by 149
“[2], this form of cell death involves the kinase activity of receptor-interacting protein 1 (RIP1) and RIP3, which leads to the formation of a complex termed necrosome [3].”
BackgroundNecrotic cell death in atherosclerosis
Martinet, W., Schrijvers, D. M., & Meyer, G. R. Y. D. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0192-x · Cited by 160
“A specific and potent small-molecule inhibitor of necrosis, known as necrostatin-1 (Nec-1), has been identified by screening for chemical inhibitors of necrotic cell death in U937 cells induced by TNFa in the presence of caspase inhibitors [16].”
BackgroundMcKernan, D. P., Dinan, T. G., & Cryan, J. F. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.04.006 · Cited by 147
“, 2000), necroptosis (Degterev et al., 2005), pyroptosis (Brennan and Cookson, 2000;”
BackgroundMechanism of Hepatocyte Apoptosis
Cao, L., Quan, X.-B., Zeng, W., Yang, X., & Wang, M.-J. (2016) · Journal of Cell Death · doi:10.4137/jcd.s39824 · Cited by 144
Eisenberg, T., Carmona‐Gutiérrez, D., Büttner, S., Tavernarakis, N., & Madeo, F. (2010) · APOPTOSIS · doi:10.1007/s10495-009-0453-4 · Cited by 154
“Thus, further biochemical understanding of the basal mechanisms that govern necrotic cell death in general is imperative to develop new strategies for therapeutic intervention of these disorders or pathological conditions [17, 18].”
BackgroundNanomaterials Toxicity and Cell Death Modalities
Stefano, D. D., Carnuccio, R., & Maiuri, M. C. (2012) · Journal of Drug Delivery · doi:10.1155/2012/167896 · Cited by 151
“The term “necroptosis” has been used as a synonym of regulated necrosis, but it was originally introduced to indicate a specific case of necrosis, which is induced by death receptor ligation and can be inhibited by the RIP-1 targeting chemical necrostatin-1 [38, 122, 129].”
BackgroundThe roles of FADD in extrinsic apoptosis and necroptosis
Lee, E.-W., Seo, J.-H., Jeong, M.-H., Lee, S.-S., & Song, J.-W. (2012) · BMB Reports · doi:10.5483/bmbrep.2012.45.9.186 · Cited by 139
Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities
Idalsoaga, F., Kulkarni, A. V., Mousa, O. Y., Arrese, M., & Arab, J. P. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00448 · Cited by 136
The NAD-dependent deacetylase SIRT2 is required for programmed necrosis
Narayan, N., Lee, I. H., Borenstein, R., Sun, J., Wong, R. P., Tong, G., Fergusson, M. M., Liu, J., Rovira, I. I., Cheng, H.-L., et al. (2012) · Nature · doi:10.1038/nature11700 · Cited by 153
RetractedNugues, A.-L., Bouazzati, H. E., Hétuin, D., Berthon, C., Loyens, A., Bertrand, E., Jouy, N., Idziorek, T., & Quesnel, B. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.347 · Cited by 152
“Necrosis can occur in either an incidental or intentional manner as a result of defined signals, and the term necroptosis has been proposed to describe this programmed necrosis.(2) Activation of the receptor-interacting protein kinase 1 (RIP1) and 3 (RIP3) proteins in the necrosome complex can induce apoptosis, necrop…”
BackgroundFunctions of caspase 8: The identified and the mysterious
Salvesen, G. S., & Walsh, C. M. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.03.005 · Cited by 136
“Using knowledge of this requirement, Yuan and colleagues screened a series of chemical compounds to identify inhibitors of necroptosis [101], a screen resulting in the identification of several “necrostatins.”
BackgroundInfluentialChen, S., Lv, X., Hu, B., Shao, Z., Wang, B., Ma, K., Lin, H., & Cui, M. (2017) · APOPTOSIS · doi:10.1007/s10495-017-1358-2 · Cited by 136
Dichotomy between RIP1- and RIP3-Mediated Necroptosis in Tumor Necrosis Factor-α-Induced Shock
Linkermann, A., Bräsen, J. H., De Zen, F., Weinlich, R., Schwendener, R. A., Green, D. R., Kunzendorf, U., & Krautwald, S. (2012) · Molecular Medicine · doi:10.2119/molmed.2011.00423 · Cited by 136
Selenium Cytotoxicity in Cancer
Wallenberg, M., Misra, S., & Björnstedt, M. (2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12207 · Cited by 145
“4 Necroptosis Necroptosis is characterized by a necrotic like cell death, with loss of plasma membrane and mitochondrial membrane potential (MMP), along with presence of autophagic activity [286].”
BackgroundThe potential role of necroptosis in inflammaging and aging
Royce, G. H., Brown‐Borg, H. M., & Deepa, S. S. (2019) · GeroScience · doi:10.1007/s11357-019-00131-w · Cited by 146
Physiopathology of the Permeability Transition Pore: Molecular Mechanisms in Human Pathology
Bonora, M., Patergnani, S., Ramaccini, D., Morciano, G., Pedriali, G., Kahsay, A., Bouhamida, E., Giorgi, C., Wieckowski, M., & Pinton, P. (2020) · Biomolecules · doi:10.3390/biom10070998 · Cited by 135
“The key upstream kinases involved in the activation of necroptosis are RIPK1 [54], RIPK3, and the substrate MLKL [55], which can be inhibited either through genetic or pharmacological methods to block this type of programmed cell death [56].”
BackgroundCostigan, A., Hollville, É., & Martin, S. J. (2023) · Current Protocols · doi:10.1002/cpz1.951 · Cited by 151
“Necroptosis can usually be inhibited by means of small molecules (e.g., necrostatin-1, see Table 2) that block the kinase activity of RIPK1 and the formation of the necrosome (RIPK1/RIPK3) complex (Degterev et al., 2005, 2008).”
BackgroundJiang, W., Bell, C. W., & Pisetsky, D. S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.10.6495 · Cited by 134
“Although caspase inhibition would be expected to diminish cell death, previous studies have shown that the stimulation of macrophages in the presence of pancaspase inhibitors actually increases cell death by a process identified as necroptosis (41).”
BackgroundThe mechanism of necroptosis in normal and cancer cells
Fulda, S. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.26428 · Cited by 152
Apoptosis in Cardiovascular Diseases: Mechanism and Clinical Implications
Kim, N.-H., & Kang, P. M. (2010) · Korean Circulation Journal · doi:10.4070/kcj.2010.40.7.299 · Cited by 138
A Mechanistic Review of Cell Death in Alcohol‐Induced Liver Injury
Wang, S., Pacher, P., De Lisle, R. C., Huang, H., & Ding, W. (2016) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.13078 · Cited by 131
“…A uthor M anuscript A uthor M anuscript A uthor M anuscript the RIP1-RIP3-MLKL (mixed lineage kinase domain-like protein)-mediated necrotic cascade, a process also referred to as necroptosis or programmed necrosis (Degterev et al., 2005, Zhang et al., 2009, Cho et al., 2009, He et al., 2009).”
BackgroundRIPK1 activation mediates neuroinflammation and disease progression in multiple sclerosis
Zelic, M., Pontarelli, F., Woodworth, L., Zhu, C., Mahan, A., Ren, Y., LaMorte, M., Gruber, R., Keane, A., Loring, P., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109112 · Cited by 133
“After 2 h, T/5z or T/S/Z stimulation upregulated pRIPK1, whereas the signal was abrogated by Nec-1s (N), a small-molecule RIPK1 kinase inhibitor (Figure 2A; Degterev et al., 2005, 2008).”
Self-citationKoshinuma, S., Miyamae, M., Kaneda, K., Kotani, J., & Figueredo, V. M. (2013) · Journal of Anesthesia · doi:10.1007/s00540-013-1716-3 · Cited by 138
“Necrostatin-1 is a small tryptophan-based molecule that has been shown to reduce infarct volume after middle cerebral artery occlusion following intracerebroventricular injection [6] and to block TNF-a-induced necrotic cell death through inhibition of RIP1 kinase activity in Jurkat cells [9].”
Modulatory profiling identifies mechanisms of small molecule-induced cell death
Wolpaw, A. J., Shimada, K., Skouta, R., Welsch, M. E., Akavia, U. D., Pe'er, D., Shaik, F., Bulinski, J. C., & Stockwell, B. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106149108 · Cited by 133
Cold stress‐induced ferroptosis involves the ASK1‐p38 pathway
Hattori, K., Ishikawa, H., Sakauchi, C., Takayanagi, S., Naguro, I., & Ichijo, H. (2017) · EMBO Reports · doi:10.15252/embr.201744228 · Cited by 140
“We next assessed the involvement of RIP1, which is a crucial regulator of necroptosis, using RIP1 kinase inhibitors: necrostatin-1 (Nec-1) and Nec-1 stable (Nec-1s) [21,34,35].”
Mechanisms of Regulated Cell Death: Current Perspectives
Santagostino, S. F., Assenmacher, C., Tarrant, J. C., Adedeji, A. O., & Radaelli, E. (2021) · Veterinary Pathology · doi:10.1177/03009858211005537 · Cited by 152
Necroptosis: A Novel Pathway in Neuroinflammation
Yu, Z., Jiang, N., Su, W., & Zhuo, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.701564 · Cited by 154
“In 2005, scientists demonstrated that delayed ischemic brain injury in a mouse model was due to necroptosis, a mechanism different from apoptosis (Degterev et al., 2005).”
BackgroundAlzheimer's Mechanisms in Ischemic Brain Degeneration
Pluta, R., Ułamek, M., & Jabłoński, M. (2009) · The Anatomical Record · doi:10.1002/ar.21018 · Cited by 133
“Recently, another neuronal death pathway called necroptosis was observed after brain ischemia (Degterev et al., 2005).”
BackgroundDivergent effects of RIP1 or RIP3 blockade in murine models of acute liver injury
Deutsch, M., Graffeo, C. S., Rokosh, R., Pansari, M., Ochi, A., Levie, E. M., Van Heerden, E., Tippens, D. M., Greco, S., Barilla, R., et al. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.126 · Cited by 131
Delivery of drugs and macromolecules to the mitochondria for cancer therapy
Lu, P., Bruno, B. J., Rabenau, M., & Lim, C. S. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.023 · Cited by 135
Biomarkers and Molecular Probes for Cell Death Imaging and Targeted Therapeutics
Smith, B. D., & Smith, B. D. (2012) · Bioconjugate Chemistry · doi:10.1021/bc3003309 · Cited by 144
Wen, S., Niu, Y., Lee, S. O., & Chang, C. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.07.008 · Cited by 159
“Accumulating evidences revealed that necrosis could also occur in a regulated manner [127–129], and then a new term ‘‘necroptosis’’ was introduced to describe the programmed necrosis [130].”
BackgroundRegulated cell death pathways in cardiomyopathy
Sheng, S., Li, J., Hu, X., & Wang, Y. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01068-9 · Cited by 139
“NECROPTOSIS AND CARDIOMYOPATHIES Necroptosis pathway The term “necroptosis” was first proposed by Degterev in 2005 to describe a form of programmed necrosis which differs from but also interplays with apoptosis [72].”
BackgroundDe novo pyrimidine biosynthetic complexes support cancer cell proliferation and ferroptosis defence
Yang, C., Zhao, Y., Wang, L., Guo, Z., Ma, L., Yang, R., Wu, Y., Li, X., Niu, J., Chu, Q., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01146-4 · Cited by 145
Pathophysiological role of different tubular epithelial cell death modes in acute kidney injury
Sancho-Martínez, S. M., López-Novoa, J. M., & López-Hernández, F. J. (2015) · Clinical Kidney Journal · doi:10.1093/ckj/sfv069 · Cited by 130
“After the discoveryof necroptosis and necrostatin-1 (Nec-1) as an inhibitor of necroptosis [139], new strategieswere designed for AKI treatment.”
BackgroundNecroptosis: is there a role for mitochondria?
Marshall, K. D., & Baines, C. P. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00323 · Cited by 140
“Multiple studies have shown that mitochondrial ROS is critical to the execution of necroptosis in L929 cells (He et al., 2009; Vanlangenakker et al., 2011; Ardestani et al., 2013), while HT29 and U937 cells seem to lack this requirement (Degterev et al., 2005; He et al., 2009).”
BackgroundAn outline of necrosome triggers
Vanden Berghe, T., Hassannia, B., & Vandenabeele, P. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2189-y · Cited by 131
“A series of auto- and cross-phosphorylations between RIPK1 and RIPK3 result in the formation and activation of the canonical necrosome [43, 47], which appears as an amyloid-like structure of RHIMdependent oligomerized RIPK3 [48].”
BackgroundNecrostatin-1 reverts shikonin-induced necroptosis to apoptosis
Han, W., Xie, J., Li, L., Liu, Z., & Hu, X. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0334-x · Cited by 132
“In contrast, in the necroptosis, mitochondrial potential loss caused by MIMP is an early event, which contributes significantly to the cell death [1].”
BackgroundResultInfluentialWang, Q., Liu, Z., Ren, J., Morgan, S., Assa, C., & Liu, B. (2015) · Circulation Research · doi:10.1161/circresaha.116.304899 · Cited by 129
Yoshikawa, M., Saitoh, M., Katoh, T., Seki, T., Bigi-Botterill, S. V., Shimizu, Y., Ishii, T., Okai, T., Kuno, M., Hattori, H., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01647 · Cited by 131
Yang, J., Zhao, Y., Zhang, L., Fan, H., Qi, C., Zhang, K., Liu, X., Fei, L., Chen, S., Wang, M., et al. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy089 · Cited by 126
“Although early studies in necroptosis have involved ischemic stroke (Degterev et al. 2005), and later studies”
BackgroundTAM Kinases Promote Necroptosis by Regulating Oligomerization of MLKL
Najafov, A., Mookhtiar, A. K., Luu, H. S., Ordureau, A., Pan, H., Amin, P. P., Li, Y., Lu, Q., & Yuan, J. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.05.022 · Cited by 141
Self-citationOxidative Stress and Inflammation Caused by Cisplatin Ototoxicity
Ramkumar, V., Mukherjea, D., Dhukhwa, A., & Rybak, L. P. (2021) · Antioxidants · doi:10.3390/antiox10121919 · Cited by 143
“Rather it follows a program in cells that is mediated by the receptor-interacting protein kinases (RIPKs), RIPK1 and RIPK3.”
BackgroundThe RIP1-Kinase Inhibitor Necrostatin-1 Prevents Osmotic Nephrosis and Contrast-Induced AKI in Mice
Linkermann, A., Heller, J.-O., Prókai, Á., Weinberg, J. M., De Zen, F., Himmerkus, N., Szabó, A. J., Bräsen, J. H., Kunzendorf, U., & Krautwald, S. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012121169 · Cited by 130
Wagner, S., Satpathy, S., Beli, P., & Choudhary, C. (2016) · The EMBO Journal · doi:10.15252/embj.201694300 · Cited by 144
“Therefore, we included necrostatin-1 (NEC-1), a RIPK1 inhibitor (Degterev et al , 2005) that prevents the assembly of RIPK1-RIPK3 complex, as a positive control.”
Ling, Y., Xia, X., Liang, H., Wang, W., Zhang, H., Liu, L., Liu, W., Li, Z., Tan, C., & Mao, Z. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202210988 · Cited by 134
Degradation of HK2 by chaperone-mediated autophagy promotes metabolic catastrophe and cell death
Xia, H.-G., Najafov, A., Geng, J., Galan-Acosta, L., Han, X., Guo, Y., Shan, B., Zhang, Y., Norberg, E., Zhang, T., et al. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201503044 · Cited by 122
“This was not inhibited by either zVAD.fmk, a pan caspase inhibitor, or 7-Cl-O-Nec-1 (7N-1), a RIPK1 inhibitor (Degterev et al., 2005).”
Self-citationUnderstanding cell cycle and cell death regulation provides novel weapons against human diseases
Wiman, K. G., & Zhivotovsky, B. (2017) · Journal of Internal Medicine · doi:10.1111/joim.12609 · Cited by 143
Programmed necrosis in heart disease: Molecular mechanisms and clinical implications
Zhu, H., & Sun, A. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.01.018 · Cited by 130
The regulation of necroptosis by post-translational modifications
Meng, Y., Sandow, J. J., Czabotar, P. E., & Murphy, J. M. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-020-00722-7 · Cited by 136
Cell death and ischemia-reperfusion injury in lung transplantation
Capuzzimati, M., Hough, O., & Liu, M. (2022) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2022.05.013 · Cited by 146
Regulated cell death: discovery, features and implications for neurodegenerative diseases
Cui, J., Zhao, S., Li, Y., Zhang, D., Wang, B., Xie, J., & Wang, J. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00799-8 · Cited by 138
“Necrostatin-1 (Nec-1) is a small molecular inhibitor of necroptosis, which blocks the activation of RIPK1 [186].”
BackgroundInfluentialSelf-citationMitochondria as targets for chemotherapy
Gogvadze, V. G., Orrenius, S., & Zhivotovsky, B. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0323-0 · Cited by 140
“One such mechanism, called necroptosis, has recently been described [ 11 ].”
BackgroundThe NLRP3 inflammasome renders cell death pro-inflammatory
Gaidt, M. M., & Hornung, V. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.11.013 · Cited by 124
Vieira, M., Fernandes, J., Carreto, L., Anuncibay-Soto, B., Santos, M., Han, J., Fernández-López, A., Duarte, C. B., Carvalho, A. L., & Santos, A. E. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.04.002 · Cited by 125
“…brain ischemia paradigms have been suggested to have a component of necroptotic neuronal death, based on the neuroprotective effect of Nec-1 (Degterev et al., 2005; Xu et al., 2010; Northington et al., 2011), to date, changes in the protein levels of the necrosome components have not been…”
InfluentialNecrostatin-1 Suppresses Autophagy and Apoptosis in Mice Traumatic Brain Injury Model
Wang, Y.-Q., Wang, L., Zhang, M., Wang, T., Bao, H., Liu, W., Dai, D.-K., Zhang, L., Chang, P., Dong, W., et al. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0791-4 · Cited by 129
TNF Alpha and Fas Mediate Tissue Damage and Functional Outcome after Traumatic Brain Injury in Mice
Berrrrpohl, D., You, Z., Lo, E. H., Kim, H.-H., & Whalen, M. J. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600487 · Cited by 127
Lin, F., Yang, Y., Wei, S., Huang, X., Peng, Z., Xiao, K., Zeng, Z., & Song, Y. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s242521 · Cited by 123
Mittal, S., Kumar, V., Dhiman, N., Chauhan, L. K. S., Pasricha, R., & Pandey, A. K. (2016) · Scientific Reports · doi:10.1038/srep39548 · Cited by 123
“Previously, it has been reported that GD mainly enters into the cells by endocytosis/phagocytosis depending upon their interaction with cellular membrane 45 .”
Dong, Y., Yu, H., Li, X., Bian, K., Zheng, Y., Dai, M., Feng, X., Sun, Y., He, Y. T., Yu, B., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02567-y · Cited by 132
“Necroptosis is a form of programmed necrotic cell death that is induced by the activation of death receptors (DRs) including tumor necrosis factor (TNF) receptor 1 (TNFR1) [4, 5].”
BackgroundAutophagy after Experimental Intracerebral Hemorrhage
He, Y., Wan, S., Hua, Y., Keep, R. F., & Xi, G. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600578 · Cited by 124
“Recent studies indicate that autophagy occurs in cerebral ischemia (Adhami et al, 2006; Degterev et al, 2005), and enhancing autophagy provides a powerful protective mechanism against ischemia/reperfusion injury in cardiac myocytes (Hamacher-Brady et al, 2006).”
BackgroundLu, J. V., Weist, B. M., van Raam, B. J., Marro, B. S., Nguyen, L. V., Srinivas, P., Bell, B. D., Luhrs, K. A., Lane, T. E., Salvesen, G. S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102779108 · Cited by 122
“By using a small-molecule library, Yuan and colleagues identified a family of molecules termed necrostatins that are capable of binding to RIPK1 and blocking DR-induced necrosis (11), a process defined as necroptosis.”
MethodDownes, C. E., & Crack, P. J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00864.x · Cited by 122
“One group has labelled one of these forms ‘necroptosis’, which is a description of Fas receptor signalling that can activate alternative pathways to the extrinsic pathways, leading to autophagy (Degterev et al., 2005).”
BackgroundMicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1
Liu, J., van Mil, A., Vrijsen, K., Zhao, J., Gao, L., Metz, C. H. G., Goumans, M.-J., Doevendans, P. A., & Sluijter, J. P. G. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01104.x · Cited by 123
“The feasibility of various cell sources and different cell delivery methods have been extensively explored [21, 25–29].”
Targeting cell death in the reperfused heart: Pharmacological approaches for cardioprotection
Oerlemans, M. I. F. J., Koudstaal, S., Chamuleau, S. A. J., de Kleijn, D. P. V., Doevendans, P. A., & Sluijter, J. P. G. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.03.055 · Cited by 130
“After discovery of Nec-1, a small molecule capable of inhibiting the kinase activity of RIP1 [33,34], the group of Yuan focused on the development of Nec-1”
BackgroundInfluentialQu, J., Chen, W., Hu, R., & Feng, H. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/2592935 · Cited by 124
“Necroptosis is a type of programmed cell death that has been found in the pathological process of ICH [28, 29].”
BackgroundHou, J., Ju, J., Zhang, Z., Zhao, C., Li, Z., Zheng, J., Tian, S., Zhang, H., Hu, L., Yu, X., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1735-6 · Cited by 133
Self-citationThe p53-cathepsin axis cooperates with ROS to activate programmed necrotic death upon DNA damage
Tu, H.-C., Ren, D., Wang, G. X., Chen, D. Y., Westergard, T. D., Kim, H., Sasagawa, S., Hsieh, J. J.-D., & Cheng, E. H.-Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808173106 · Cited by 121
“Recently, a small molecule inhibitor of RIP1 kinase, necrostatin-1, was reported to provide protection in a murine ischemic brain injury model (36, 37).”
BackgroundStructure–activity relationship analysis of a novel necroptosis inhibitor, Necrostatin-5
Wang, K., Li, J., Degterev, A., Hsu, E., Yuan, J., & Yuan, C. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.11.056 · Cited by 121
Self-citationNon-kinase targets of protein kinase inhibitors
Munoz, L. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.266 · Cited by 135
RIPK 3 in cell death and inflammation: the good, the bad, and the ugly
Orozco, S. L., & Oberst, A. (2017) · Immunological Reviews · doi:10.1111/imr.12536 · Cited by 130
He, L., Wang, K., Zheng, Y., Cao, J., Zhang, M., Tan, C., Ji, L., & Mao, Z. (2018) · Dalton Transactions · doi:10.1039/c8dt00783g · Cited by 123
Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1
Zhang, T., Xu, D., Trefts, E., Lv, M., Inuzuka, H., Song, G., Liu, M., Lu, J., Liu, J., Chu, C., et al. (2023) · Science · doi:10.1126/science.abn1725 · Cited by 129
Self-citationLiu, M., Wu, W., Li, H., Li, S., Huang, L.-T., Yang, Y.-Q., Sun, Q., Wang, C.-X., Yu, Z., & Hang, C.-H. (2015) · The Journal of Spinal Cord Medicine · doi:10.1179/2045772314y.0000000224 · Cited by 124
A new kind of cell suicide: mechanisms and functions of programmed necrosis
Sun, L., & Wang, X. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.10.003 · Cited by 136
Metallomics insights into the programmed cell death induced by metal-based anticancer compounds
Tan, C., Lu, Y., Ji, L., & Mao, Z. (2014) · Metallomics · doi:10.1039/c3mt00225j · Cited by 143
Du, W., Gu, M., Hu, M., Pinchi, P., Chen, W., Ryan, M., Nold, T. M., Bannaga, A., & Xu, H. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109848 · Cited by 128
“To explore the cell death mechanism(s) underlying ML-SA’s cytotoxicity, we tested a panel of established inhibitors for various cell death pathways, which included necrostatin-1 (Nec-1) for necroptosis (Degterev et al., 2005), pan-caspase inhibitor z-VAD-fmk for apoptosis (Cain et al.”
MethodHuman RIPK3 maintains MLKL in an inactive conformation prior to cell death by necroptosis
Meng, Y., Davies, K. A., Fitzgibbon, C., Young, S. N., Garnish, S. E., Horne, C. R., Luo, C. S., Garnier, J., Liang, L., Cowan, A. D., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27032-x · Cited by 130
“Wd-type D142N Ureated S(2)27A lysate Sf21: human MLKL (190-471) + human RIPK3 (1-316)”
Mechanisms and consequences of entosis
Krishna, S., & Overholtzer, M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2207-0 · Cited by 118
“necroptosis [8] and ferroptosis [9]) can eliminate cells during development [43] or carcinogenesis [24], and contribute to killing cells that are infected by viruses [40] or damaged by ischemia–reperfusion [33–35].”
Wang, M., Zhou, C., Wong, M., & Che, C. (2010) · Chemistry - A European Journal · doi:10.1002/chem.200902387 · Cited by 119
Xuan, Y., & Hu, X. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.09.029 · Cited by 123
“on the following aspects [25,26]: (1) Nec-1 specifically inhibits necroptosis, but not affect apoptosis and autophagy; (2) Nec-1 does not affect the general physiology of healthy cells, including ATP levels, mitochondria membrane potential, plasmamembrane integrity, cell shape and size, cell cycle distribution, prolif…”
BackgroundInfluentialRen, Y., Su, Y., Sun, L., He, S., Meng, L., Liao, D., Liu, X., Ma, Y., Liu, C., Li, S., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01196 · Cited by 118
Yamanaka, K., Saito, Y., Yamamori, T., Urano, Y., & Noguchi, N. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.236273 · Cited by 117
Yu, H., Zhang, Z., Chen, J., Pei, A., Hua, F., Qian, X., He, J., Liu, C., & Xu, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033584 · Cited by 129
“necrosis, necroptosis and autophagy [4,5].”
Accumulation of Cytosolic Calcium Induces Necroptotic Cell Death in Human Neuroblastoma
Nomura, M., Ueno, A., Saga, K., Fukuzawa, M., & Kaneda, Y. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1283 · Cited by 125
Kiełbik, M., Szulc-Kiełbik, I., & Klink, M. (2021) · Cells · doi:10.3390/cells10010130 · Cited by 122
“Necroptosis (programed necrosis) is a regulated cell death type that mimics features of both apoptosis and necrosis and is also known to induce immune-related processes [9,10].”
BackgroundNeuroimmune Mechanisms Underlying Neuropathic Pain: The Potential Role of TNF-α-Necroptosis Pathway
Duan, Y.-W., Chen, S., Li, Q., & Zang, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137191 · Cited by 128
“Stimulation of the Fas/TNFR family can not only trigger a canonical ‘extrinsic’ apoptotic pathway but also activate necroptosis inhibited by necrostatin-1 (Nec-1), a specific and potent small-molecule substance, in the absence of intracellular apoptotic signalling [65].”
BackgroundInfluential
Metadata
- Authors
- Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Cuny, G. D., Mitchison, T. J., Moskowitz, M. A., & Yuan, J.
- Affiliations
- Harvard University (US)
- Brigham and Women's Hospital (US)
- Tokyo Metropolitan Institute of Medical Science (JP)
- Corresponding author
- Yuan, Junying
- ORCID
- Venue
- Nature Chemical Biology
- Published
- 2005-05-29
- Volume
- 1
- Issue
- 2
- Pages
- 112-119
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- OpenAlex
- W2110796758
- Cited by
- 3,068
- References
- 39
- Citations by year
- 2026: 144 · 2025: 217 · 2024: 239 · 2023: 240 · 2022: 237 · 2021: 208 · 2020: 181 · 2019: 150 · 2018: 190 · 2017: 171 · 2016: 161 · 2015: 150 · 2014: 180 · 2013: 126 · 2012: 111
- FWCI
- 15.99
- Type
- journal article
- Language
- en
- Update notices
- addendum (2013-02-15)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Chemical Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Health Assistance Foundation
- National Institute on Aging (R37AG012859)
- National Institute of General Medical Sciences (R01GM064703, R01 GM64703)
- National Institute of Neurological Disorders and Stroke (R01NS037141, R01 NS37141-08)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- necroptosis, non-apoptotic cell death, necrostatin-1, ischemic brain injury, stroke, neuroprotection, autophagy, regulated cell death, small molecule inhibitors
- MeSH terms
- Animals, Brain Ischemia, Humans, Imidazoles, Indoles, Molecular Structure, Signal Transduction, Cell Death, Protein Serine-Threonine Kinases, Cell Line, Tumor, Protein Kinase Inhibitors, Tumor Necrosis Factor Receptor-Associated Peptides and Proteins, Mice, Receptor-Interacting Protein Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.